Literature DB >> 30294723

Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

Timothy Tilert1, Ryne Paulose-Ram1, Donna Howard2, James Butler2, Sunmin Lee3, Min Qi Wang2.   

Abstract

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a respiratory disease that often goes undiagnosed, particularly in its early stages.
OBJECTIVE: To examine sociodemographic, general health, and COPD specific factors, including severity of lung obstruction, that are associated with healthcare provider-diagnosed COPD among U.S. adults.
METHODS: NHANES cross-sectional data collected from 2007-2012 on adults aged 40-79 years (n=10,219) were analyzed. The primary outcome was self-reported COPD diagnosis with predictive factors analyzed via chi-square and logistic regression analyses.
RESULTS: During 2007-2012, 5.2% of US adults aged 40-79 reported being diagnosed with COPD. Among those diagnosed, 50.8% reported fair or poor health, 47.1% were currently smoking cigarettes, 49.1% were taking prescription respiratory medication, 36.4% had moderate or worse lung obstruction, and nearly 90% had one or more respiratory symptoms. Logistic regression revealed positive associations between receiving a COPD diagnosis and the following: being white (AOR: 3.08, 95% CI: 1.82-5.20); being aged 60-79 years (AOR: 1.65, 95% CI: 1.07-2.53); reporting fair/poor health (AOR: 2.91, CI: 1.55-5.46); having 4-9 (AOR: 3.5, CI: 1.3-9.4) or 10 or more healthcare visits in prior year (AOR: 5.06, CI: 1.62-15.77); being a former (AOR: 1.75, CI: 1.2-2.5) or current smoker (AOR: 1.70, CI: 1.17-2.48); having more severe lung obstruction (AOR: 4.90, CI: 3.28-7.32); having 3 or more respiratory symptoms (AOR: 22.07, CI: 12.03-40.49).
CONCLUSIONS: Multiple factors are associated with self-reported COPD diagnosis with number of reported respiratory symptoms having the strongest association. After controlling for other factors, having mild lung obstruction was not associated with being diagnosed.

Entities:  

Keywords:  COPD; Diagnosis; NHANES; Prevalence; Smoking; Spirometry

Year:  2018        PMID: 30294723      PMCID: PMC6169793     

Source DB:  PubMed          Journal:  EC Pulmonol Respir Med


  17 in total

1.  Interpretative strategies for lung function tests.

Authors:  R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Chronic obstructive pulmonary disease among adults--United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-11-23       Impact factor: 17.586

4.  Smoking prevalence and cessation characteristics among U.S. adults with and without COPD: findings from the 2011 Behavioral Risk Factor Surveillance System.

Authors:  Gillian L Schauer; Anne G Wheaton; Ann M Malarcher; Janet B Croft
Journal:  COPD       Date:  2014-05-19       Impact factor: 2.409

5.  The View of the Turkish Thoracic Society on the Report of the GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of COPD.

Authors:  Nurdan Köktürk; Alev Gürgün; Elif Şen; Ali Kocabaş; Mehmet Polatlı; Sibel Atış Naycı; Lütfi Çöplü; Emel Tellioğlu; Funda Elmas; Ertürk Erdinç
Journal:  Turk Thorac J       Date:  2017-04-01

Review 6.  Metabolism and disposition kinetics of nicotine.

Authors:  Janne Hukkanen; Peyton Jacob; Neal L Benowitz
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

7.  Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.

Authors:  Anne Lindberg; A Bjerg; Anders Bjerg-Bäcklund; Eva Rönmark; Lars-Gunnar Larsson; Bo Lundbäck
Journal:  Respir Med       Date:  2005-06-21       Impact factor: 3.415

8.  Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors.

Authors:  Cara N Halldin; Brent C Doney; Eva Hnizdo
Journal:  Chron Respir Dis       Date:  2014-12-24       Impact factor: 2.444

9.  Associations of Self-Reported Cigarette Smoking with Chronic Obstructive Pulmonary Disease and Co-Morbid Chronic Conditions in the United States.

Authors:  Timothy J Cunningham; Earl S Ford; Italia V Rolle; Anne G Wheaton; Janet B Croft
Journal:  COPD       Date:  2014-09-10       Impact factor: 2.409

10.  National health and nutrition examination survey: plan and operations, 1999-2010.

Authors:  George Zipf; Michele Chiappa; Kathryn S Porter; Yechiam Ostchega; Brenda G Lewis; Jennifer Dostal
Journal:  Vital Health Stat 1       Date:  2013-08
View more
  7 in total

1.  Activity-related dyspnea in older adults participating in the Canadian Longitudinal Study on Aging.

Authors:  Chris P Verschoor; Sabit Cakmak; Anna O Lukina; Robert E Dales
Journal:  J Gen Intern Med       Date:  2022-07-11       Impact factor: 6.473

2.  Validation of Questionnaire-based Case Definitions for Chronic Obstructive Pulmonary Disease.

Authors:  Lydia Feinstein; Jesse Wilkerson; Paivi M Salo; Nathaniel MacNell; Matthew F Bridge; Michael B Fessler; Peter S Thorne; Angelico Mendy; Richard D Cohn; Matthew D Curry; Darryl C Zeldin
Journal:  Epidemiology       Date:  2020-05       Impact factor: 4.860

3.  Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial.

Authors:  Elizabeth R Stevens; Lei Lei; Charles M Cleland; Mahathi Vojjala; Omar El-Shahawy; Kenneth I Berger; Thomas R Kirchner; Scott E Sherman
Journal:  Addict Sci Clin Pract       Date:  2022-01-06

4.  Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Laura M Paulin; Michael J Halenar; Kathryn C Edwards; Kristin Lauten; Cassandra A Stanton; Kristie Taylor; Dorothy Hatsukami; Andrew Hyland; Todd MacKenzie; Martin C Mahoney; Ray Niaura; Dennis Trinidad; Carlos Blanco; Wilson M Compton; Lisa D Gardner; Heather L Kimmel; Dana Lauterstein; Daniela Marshall; James D Sargent
Journal:  Respir Res       Date:  2022-10-01

5.  Cigarette Smoking Among US Adults With Selected Chronic Diseases Associated With Smoking, 2010-2019.

Authors:  Caitlin G Loretan; Monica E Cornelius; Ahmed Jamal; Yiling J Cheng; David M Homa
Journal:  Prev Chronic Dis       Date:  2022-09-29       Impact factor: 4.354

6.  TNFRSF12A and CD38 Contribute to a Vicious Circle for Chronic Obstructive Pulmonary Disease by Engaging Senescence Pathways.

Authors:  Yan Dong; Hongbao Cao; Rongyuan Cao; Ancha Baranova
Journal:  Front Cell Dev Biol       Date:  2020-05-27

7.  Trends and factors of botanical dietary supplement use among US adults with COPD from 1999 to 2016.

Authors:  Yanjie Sun; Rongying Wang; Weiwei Tang; Chao Li; Nan Huo
Journal:  PLoS One       Date:  2020-09-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.